Nodelman Oleg

Avg. Two Year Performance

(14%) Avg. Purchase Return
(7%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(2%)(8%)(11%)(12%)(14%)
Purchase Success Rate1 of 51 of 50 of 50 of 50 of 5
Average Sale Return(6%)(18%)(13%)0%0%
Sale Success Rate0 of 20 of 20 of 20 of 20 of 2

Prothena Corporation plc

Drugs » Biotechnology

Director, 10% Owner:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Anaptysbio, Inc

Other » Other

Director, 10% Owner:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Kindred Biosciences, Inc.

Drugs » Biotechnology

Director:

Holdings: 1.16M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Nuvation Bio Inc.

Other » Other

Director:

Holdings: 19.21M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Avigen Inc.

Drugs » Diagnostic Substances

:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--